CSL Ltd R&D Investor Briefing 2021 Transcript
Ladies and gentlemen, welcome to CSL's Annual Research and Development Briefing. Online with us today is Dr. Bill Mezzanotte, Executive Vice President, Head of Research and Development and Chief Medical Officer. He'll be joined by several of his senior team. Also joining us, once again, is Bill Campbell, Executive Vice President and Chief Commercial Officer. Bill will be providing us with some market insights and CSL's product portfolio. Please be aware this presentation as well as the Q&A session is being webcast. And lastly, before we start, I draw your attention to the forward statement disclaimer within the slide deck.
I'll now pass you over to Bill Mezzanotte. Bill?
Thanks, Mark, and welcome once again to the CSL R&D Day, where we try in a relatively short period of time to summarize and highlight all the activities of the year. Once again, we are conducting this meeting virtually. And while I
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |